Hedge Fund - Euclidean Capital
Pmv Pharmaceuticals Inc. (PMVP)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $2,864,131 | 1.08% | 2,627,643 | $1.36 |
| 2 | 2024 - Q4 (2024-12-31) | $3,967,741 | 0.53% | 2,627,643 | $1.58 |
| 3 | 2024 - Q3 (2024-09-30) | $3,915,188 | 0.43% | 2,627,643 | $1.55 |
| 4 | 2024 - Q2 (2024-06-30) | $4,256,782 | 0.53% | 2,627,643 | $1.80 |
| 5 | 2024 - Q1 (2024-03-31) | $4,466,993 | 0.57% | 2,627,643 | $1.87 |
| 6 | 2023 - Q4 (2023-12-31) | $8,145,693 | 0.91% | 2,627,643 | $2.65 |
| 7 | 2023 - Q3 (2023-09-30) | $16,133,728 | 3.51% | 2,627,643 | $6.88 |
| 8 | 2023 - Q2 (2023-06-30) | $15,933,215 | 4.09% | 2,545,242 | $5.24 |
| 9 | 2023 - Q1 (2023-03-31) | $11,147,056 | 9.78% | 2,336,909 | $7.04 |
| 10 | 2022 - Q4 (2022-12-31) | $20,331,108 | 19.02% | 2,336,909 | $10.66 |
| 11 | 2022 - Q3 (2022-09-30) | $27,809,000 | 25.81% | 2,336,909 | $14.45 |
| 12 | 2022 - Q2 (2022-06-30) | $33,301,000 | 28.32% | 2,336,909 | $14.55 |
| 13 | 2022 - Q1 (2022-03-31) | $48,654,000 | 28.27% | 2,336,909 | $17.64 |
| 14 | 2021 - Q4 (2021-12-31) | $53,983,000 | 30.69% | 2,336,909 | $24.16 |
| 15 | 2021 - Q3 (2021-09-30) | $82,540,000 | 40.12% | 2,769,813 | $31.93 |
| 16 | 2021 - Q2 (2021-06-30) | $133,520,000 | 43.33% | 3,908,677 | $33.40 |
| 17 | 2021 - Q1 (2021-03-31) | $137,461,000 | 45.99% | 4,179,416 | $39.42 |
| 18 | 2020 - Q4 (2020-12-31) | $257,076,000 | 54.42% | 4,179,416 | $39.23 |
The displayed share prices are average quarterly stock market prices.